We are dedicated to revolutionizing the management of vascular diseases, specifically Abdominal Aortic Aneurysm (AAA) and Peripheral Arterial Disease (PAD). Our mission is to predict the risk of cardiovascular events and disease progression, ultimately improving the quality of life and care for patients.
For the first time, VASCUL-AID offers a groundbreaking solution to identify patients who are at high risk for AAA growth or PAD progression, enabling early intervention and personalized prevention strategies. Our cutting-edge AI-driven platform integrates a wide range of data, including imaging, proteomic and genomic data, as well as lifestyle information from wearable devices. This comprehensive approach allows us to deliver clinically relevant and cost-effective predictions, supporting both patients and clinicians in making better-informed decisions.
Patient day Dec 11
On Monday December 11th, a patient day for patients with peripheral arterial disease and an abdominal aortic aneurysm will be organized in the Amsterdam University Medical Center, location AMC, in the Netherlands.
At VASCUL-AID, we understand the importance of effective communication between clinicians and patients. That’s why our platform incorporates visualization tools that enhance this interaction, empowering you to take an active role in your own care. Our patient communication app, together with the clinical dashboard, facilitates seamless collaboration and ensures that you receive the most personalized and ethical care possible.
Join us on this groundbreaking journey towards personalized vascular disease management. Experience the power of VASCUL-AID as we redefine the future of healthcare, one patient at a time.
Together, we can make a difference in your health and well-being.